Healthcare (Medicare)

SB 2370 sets a $25 maximum out-of-pocket cost for a 30-day supply of insulin drugs and related medical supplies (like test strips, syringes, and glucose meters) under most North Dakota health insurance plans. It directly affects residents with diabetes who rely on insulin coverage through private insurance, requiring plans to cap costs at $25 for both insulin medications and essential supplies. The bill prohibits insurers from imposing deductibles, copayments, or other cost-sharing that exceeds these limits, while excluding Medicare Part D plans and devices like insulin pumps. It amends existing insurance coverage laws to enforce these caps, with the law set to expire on July 31, 2025.